Covered recipient · General Payments record
TRUSHA NARENDRA SHAH
Allopathic & Osteopathic Physicians Pain Medicine Interventional Pain Medicine
General Payments · PY2018–2024
$9,953.15
- Reported across 163 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $362.21 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $114.26 | 6 |
| Nevro Corp. | $83.26 | 4 |
| Medtronic, Inc. | $65.45 | 3 |
| Collegium Pharmaceutical, Inc. | $41.85 | 2 |
| SPR Therapeutics, Inc | $23.93 | 1 |
| SCILEX PHARMACEUTICALS INC. | $18.44 | 1 |
| Bioventus LLC | $15.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.45 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106068002 | CMS |
| ABBVIE INC. | $22.98 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106068004 | CMS |
| ABBVIE INC. | $20.11 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106068006 | CMS |
| ABBVIE INC. | $15.07 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106068008 | CMS |
| ABBVIE INC. | $23.36 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106068010 | CMS |
| ABBVIE INC. | $19.29 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106068012 | CMS |
| Bioventus LLC | $15.02 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137449195 | CMS |
| Collegium Pharmaceutical, Inc. | $23.07 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135211965 | CMS |
| Collegium Pharmaceutical, Inc. | $18.78 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135336518 | CMS |
| Medtronic, Inc. | $18.00 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119438017 | CMS |
| Medtronic, Inc. | $25.99 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119438021 | CMS |
| Medtronic, Inc. | $21.46 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119438019 | CMS |
| Nevro Corp. | $19.42 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130738458 | CMS |
| Nevro Corp. | $23.19 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130738454 | CMS |
| Nevro Corp. | $23.26 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130738456 | CMS |
| Nevro Corp. | $17.39 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130738452 | CMS |
| SCILEX PHARMACEUTICALS INC. | $18.44 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136246738 | CMS |
| SPR Therapeutics, Inc | $23.93 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104944388 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.